Psychemedics Releases 2025 Workforce Insights Report
16 Jun 2025 //
GLOBENEWSWIRE
Psychemedics Named Most Innovative Drug Testing Company
16 May 2025 //
GLOBENEWSWIRE
Psychemedics Launches Quartile Reporting For Drug Testing Insights
03 Mar 2025 //
GLOBENEWSWIRE
Psychemedics Reminds Stockholders to Vote for Annual Meeting
18 Nov 2024 //
GLOBENEWSWIRE
Psychemedics Corporation Reports Q3 2024 Financial Results
12 Nov 2024 //
GLOBENEWSWIRE
Psychemedics Releases Education Insights Report On Drug Trends
26 Sep 2024 //
GLOBENEWSWIRE
Psychemedics Corporation Launches New Ketamine Hair Testing Service
29 Aug 2024 //
GLOBENEWSWIRE
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
13 Aug 2024 //
GLOBENEWSWIRE
Psychemedics To Terminate Registration Of Its Common Stock
12 Aug 2024 //
GLOBENEWSWIRE
Psychemedics Unveils Inaugural Insights Report on Drug Trends via Hair Testing
21 Jun 2024 //
GLOBENEWSWIRE
Psychemedics Corporation Reports First Quarter 2024 Financial Results
14 May 2024 //
GLOBENEWSWIRE
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
21 Mar 2024 //
GLOBENEWSWIRE
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
02 Jan 2024 //
GLOBENEWSWIRE
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
27 Nov 2023 //
GLOBENEWSWIRE
Psychemedics Corporation Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Psychemedics Introduces Advanced 5-Panel Drug Screen
27 Oct 2023 //
GLOBENEWSWIRE
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
21 Sep 2023 //
GLOBENEWSWIRE
Psychemedics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 Aug 2023 //
GLOBENEWSWIRE
Psychemedics Corporation Reports Second Quarter 2023 Financial Results
11 Aug 2023 //
GLOBENEWSWIRE
Psychemedics Corporation Announces CEO Succession Plan
12 Jul 2023 //
GLOBENEWSWIRE
Psychemedics Corporation Reports1Q 2023 FYR and Declares Cash Dividend
09 May 2023 //
GLOBENEWSWIRE
Psychemedics Reports Fourth Quarter and Full Year 2022 Financial Results
21 Mar 2023 //
GLOBENEWSWIRE
Psychemedics Corporation Reports 3Q 2022 Financial Results
09 Nov 2022 //
GLOBENEWSWIRE
Psychemedics Corp Reports Second Quarter 2022 Financial Results
09 Aug 2022 //
GLOBENEWSWIRE
Psychemedics Announces Two New Director Nominees for Meeting of Stockholders
09 Jun 2022 //
GLOBENEWSWIRE
Psychemedics Corp Reports First Quarter 2022 Financial Results
10 May 2022 //
GLOBENEWSWIRE
Psychemedics Corp Reports Fourth Quarter and Full Year 2021 Financial Results
29 Mar 2022 //
GLOBENEWSWIRE
Psychemedics Corp Welcomes Drew Reynolds to Its Board of Directors
22 Mar 2022 //
GLOBENEWSWIRE
Psychemedics Corp. Announced Q3 2021 Financial Results
12 Nov 2021 //
GLOBENEWSWIRE
Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results
10 Aug 2021 //
GLOBENEWSWIRE
Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results
10 Aug 2021 //
GLOBENEWSWIRE

Market Place
Sourcing Support